CD4+ T lymphocytes and viral load in patients with AIDS debut who receive antiretroviral therapy

5^th International Conference on HIV/AIDS, STDs and STIs

November 13-14, 2017 Las Vegas, Nevada, USA

Hernandez Requejo D, Perez Avila J and Carr Perez A

Instituto de Medicina Tropical Pedro Kouri, Cuba
Centro de Inmunologia Molecular, Cuba

Posters & Accepted Abstracts: J AIDS Clin Res

Abstract :

Background: AIDS premiere is a form of presentation the illness caused by HIV characterized by alteration of the patient's general state, waste syndrome, opportunistâ��s infections, neoplasia and neurological alterations. Objective: CD4+ T lymphocytes levels and of viral load in patient with AIDS premiere and antiretroviral therapy, were studied to the beginning and one year after the treatment. Methods: A cross sectional prospective observational study was conducted in 55 HIV/AIDS patients, attended in the Medical Services offered by IPK during one year, which had to the beginning of the treatment CD4+ T lymphocytes counts less to 200c�©l/�µL and high viral load. Results: It was observed that there was an average rise of 262 cel per �µL in the CD4+ T-lymphocytes, as well as an average fall of 60 452 cp/�µL in viral load one year after the antiretroviral treatment. Conclusions: With this study, we can conclude that after a year of therapy, the values of CD4+ T cells recovered and the viral load levels diminished in the evaluated patients. The results of this study confirm the benefits of antiretroviral therapy, particularly for patient with AIDS premiere